Literature DB >> 8321828

Hydrolysis of carbonates, thiocarbonates, carbamates, and carboxylic esters of alpha-naphthol, beta-naphthol, and p-nitrophenol by human, rat, and mouse liver carboxylesterases.

T L Huang1, A Székács, T Uematsu, E Kuwano, A Parkinson, B D Hammock.   

Abstract

Thirty carbonates, thiocarbonates, carbamates, and carboxylic esters of alpha-naphthol, beta-naphthol, and p-nitrophenol were synthesized and tested as substrates for liver carboxylesterases from the crude microsomal fractions of human and mouse, and purified isozymes, hydrolases A and B, from rat liver microsomes. The carbonates, thiocarbonates, and carboxylic esters of alpha-naphthol were cleaved more rapidly than the corresponding beta-naphthol isomers by the mammalian liver esterases. alpha-Naphthyl esters of acetic, propionic, and butyric acids were among the best substrates tested for these enzymes. The majority of the substrates was consistently hydrolyzed at higher rates by hydrolase B compared with hydrolase A, although the Michaelis-Menten constant (Km) values of selected substrates differed widely with these two isozymes. Malathion was a 15-fold better substrate for hydrolase B than for hydrolase A. Compared with the corresponding carboxylates, the carbonate moiety of alpha- and beta-naphthol and p-nitrophenol lowered the specific activities of the enzymes by about fivefold but improved stability under basic conditions. The optimum pH of mouse liver esterase with the acetate, methyl-carbonate, and ethylthiocarbonate of alpha-naphthol was between pH 7.0 and pH 7.6. Human and mouse liver microsomal esterase activities were about five orders of magnitude lower than the esterase activities of purified rat liver hydrolase B. A relationship between the catalytic activity of the enzymes and the lipophilicity of the naphthyl substrates indicated that (i) in the alpha- and beta-naphthyl carbonate series, an inverse relationship between enzyme activity and lipophilicity of the substrates was observed, whereas (ii) in the alpha-naphthyl carboxylate series, an increase in enzyme activity with increasing lipophilicity of the substrates up to a logP value of about 4.0 was observed, after which the enzyme activity decreased.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8321828     DOI: 10.1023/a:1018987111362

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

2.  Human esterases.

Authors:  G GOMORI
Journal:  J Lab Clin Med       Date:  1953-09

3.  Atypical deacylation of the acyl enzymes formed in the reaction of -chymotrypsin with bis(4-nitrophenyl) carbonate and 0-(4-nitrophenylene) carbonate.

Authors:  T H Fife; J E Hutchins; D M McMahon
Journal:  J Am Chem Soc       Date:  1972-02-23       Impact factor: 15.419

4.  Carbonate ester prodrugs of salicylic acid. Synthesis, solubility characteristics, in vitro enzymatic hydrolysis rates, and blood levels of total salicylate following oral administration to dogs.

Authors:  L W Dittert; H C Caldwell; T Ellison; G M Irwin; D E Rivard; J V Swintosky
Journal:  J Pharm Sci       Date:  1968-05       Impact factor: 3.534

5.  Hydrolysis of 4-acetamidophenyl 2,2,2-trichloroethyl carbonate by esterolytic enzymes from various sources.

Authors:  L W Dittert; G M Irwin; E S Rattie; C W Chong; J V Swintosky
Journal:  J Pharm Sci       Date:  1969-05       Impact factor: 3.534

6.  Pig liver esterase. Reactions with alcohols, structure-reactivity correlations, and the acyl-enzyme intermediate.

Authors:  P Greenzaid; W P Jencks
Journal:  Biochemistry       Date:  1971-03-30       Impact factor: 3.162

7.  Distribution of certain 8-quinolinols and their copper(II) chelates in a series of organic solvent--aqueous pairs.

Authors:  H A Mottola; H Freiser
Journal:  Talanta       Date:  1966-01       Impact factor: 6.057

8.  Substituted trifluoroketones as potent, selective inhibitors of mammalian carboxylesterases.

Authors:  M B Ashour; B D Hammock
Journal:  Biochem Pharmacol       Date:  1987-06-15       Impact factor: 5.858

9.  Structure-metabolism relationships in the hydrolysis of nicotinate esters by rat liver and brain subcellular fractions.

Authors:  A Durrer; B Walther; A Racciatti; G Boss; B Testa
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

10.  Mass spectrometry in structural and stereochemical problems. CXIV. Electron impact induced rearrangement of thiocarbonates, carbamates, and thiocarbamates.

Authors:  J B Thomson; P Brown; C Djerassi
Journal:  J Am Chem Soc       Date:  1966-09-05       Impact factor: 15.419

View more
  19 in total

1.  Structural requirements for the antiproliferative activity of pre-mRNA splicing inhibitor FR901464.

Authors:  Sami Osman; Brian J Albert; Yanping Wang; Miaosheng Li; Nancy L Czaicki; Kazunori Koide
Journal:  Chemistry       Date:  2010-11-19       Impact factor: 5.236

2.  Ethynylphenyl carbonates and carbamates as dual-action acetylcholinesterase inhibitors and anti-inflammatory agents.

Authors:  Jaya Saxena; David Meloni; Mou-Tuan Huang; Diane E Heck; Jeffrey D Laskin; Ned D Heindel; Sherri C Young
Journal:  Bioorg Med Chem Lett       Date:  2015-10-23       Impact factor: 2.823

3.  Cationic cholesterol derivative efficiently delivers the genes: in silico and in vitro studies.

Authors:  Jasmin Monpara; Divya Velga; Tripti Verma; Sanjay Gupta; Pradeep Vavia
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

4.  Individual variability in esterase activity and CYP1A levels in Chinook salmon (Oncorhynchus tshawytscha) exposed to esfenvalerate and chlorpyrifos.

Authors:  Craig E Wheelock; Kai J Eder; Inge Werner; Huazhang Huang; Paul D Jones; Benjamin F Brammell; Adria A Elskus; Bruce D Hammock
Journal:  Aquat Toxicol       Date:  2005-08-30       Impact factor: 4.964

5.  Structure-activity relationships for substrates and inhibitors of mammalian liver microsomal carboxylesterases.

Authors:  T L Huang; T Shiotsuki; T Uematsu; B Borhan; Q X Li; B D Hammock
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

6.  Integrin-Targeting Knottin Peptide-Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation.

Authors:  Nick Cox; James R Kintzing; Mark Smith; Gerald A Grant; Jennifer R Cochran
Journal:  Angew Chem Int Ed Engl       Date:  2016-06-15       Impact factor: 15.336

7.  Characterization of pulmonary alveolar esterases of the primate Cercopithecus pygerythrus.

Authors:  H M Leng; J A Syce
Journal:  Pharm Res       Date:  1997-02       Impact factor: 4.200

8.  Fluorogenic label to quantify the cytosolic delivery of macromolecules.

Authors:  Tzu-Yuan Chao; Ronald T Raines
Journal:  Mol Biosyst       Date:  2013-01-22

9.  Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic window.

Authors:  Jack L Sloane; Nancy L Benner; Katherine N Keenan; Xiaoyu Zang; Mohamed S A Soliman; Xiaomeng Wu; Melanie Dimapasoc; Tae-Wook Chun; Matthew D Marsden; Jerome A Zack; Paul A Wender
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-05       Impact factor: 11.205

Review 10.  Peptide-Drug Conjugates with Different Linkers for Cancer Therapy.

Authors:  Mona Alas; Azam Saghaeidehkordi; Kamaljit Kaur
Journal:  J Med Chem       Date:  2020-12-31       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.